Masimo Corp. (MASI)
NASDAQ:MASI
MASI Stock Chart & Stats
$178.32
$0.33(0.20%)
At close: 4:00 PM EST
$178.32
$0.33(0.20%)
Day’s Range― - ―
52-Week Range$125.94 - $179.00
Previous CloseN/A
Volume102.94K
Average Volume (3M)1.61M
Market Cap
$9.31B
Enterprise Value$9.75B
Total Cash (Recent Filing)$152.30M
Total Debt (Recent Filing)$559.30M
Price to Earnings (P/E)―
Beta0.92
Next Earnings
May 12, 2026EPS Estimate
1.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding52,362,810
10 Day Avg. Volume858,373
30 Day Avg. Volume1,607,246
Financial Highlights & Ratios
PEG Ratio0.89
Price to Book (P/B)9.47
Price to Sales (P/S)4.47
P/FCF Ratio34.52
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue6.39
Enterprise Value/Gross Profit10.32
Enterprise Value/Ebitda28.28
Forecast
1Y Price Target
$180.00Price Target Upside0.94% Upside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)5.91
Revenue Forecast (FY)$1.62B
Bulls Say, Bears Say
Bulls Say
Acquisition PremiumDanaher's agreed acquisition of Masimo carries a substantial premium that makes the offer attractive to shareholders and lowers the chance of a higher competing bid.
Strategic Scale And InnovationDanaher's diagnostics business is positioned to help Masimo scale internationally and accelerate product innovation, supporting potential long-term growth.
Stronger-than-expected ResultsMasimo reported revenue, adjusted earnings, and product shipments above analyst consensus, signaling resilient demand for core products.
Bears Say
Analyst Downgrades And Coverage ChangesSeveral analysts downgraded Masimo or removed ratings because the announced transaction makes prior price targets and company-focused recommendations inapplicable.
Limited Upside From Deal PriceShares trading close to the offer price constrain additional upside for investors, reducing the likelihood of material public-market gains.
Reduced Public DisclosureCancellation of the scheduled earnings call and suspension of certain updates decreases the amount of public company information available to investors.
Masimo News
MASI FAQ
What was Masimo Corp.’s price range in the past 12 months?
Masimo Corp. lowest stock price was $125.94 and its highest was $179.00 in the past 12 months.
What is Masimo Corp.’s market cap?
Masimo Corp.’s market cap is $9.31B.
When is Masimo Corp.’s upcoming earnings report date?
Masimo Corp.’s upcoming earnings report date is May 12, 2026 which is in 28 days.
How were Masimo Corp.’s earnings last quarter?
Masimo Corp. released its earnings results on Feb 26, 2026. The company reported -$0.18 earnings per share for the quarter, missing the consensus estimate of $1.479 by -$1.659.
Is Masimo Corp. overvalued?
According to Wall Street analysts Masimo Corp.’s price is currently Undervalued.
Does Masimo Corp. pay dividends?
Masimo Corp. pays a Notavailable dividend of $1 which represents an annual dividend yield of N/A. See more information on Masimo Corp. dividends here
What is Masimo Corp.’s EPS estimate?
Masimo Corp.’s EPS estimate is 1.43.
How many shares outstanding does Masimo Corp. have?
Masimo Corp. has 52,362,810 shares outstanding.
What happened to Masimo Corp.’s price movement after its last earnings report?
Masimo Corp. reported an EPS of -$0.18 in its last earnings report, missing expectations of $1.479. Following the earnings report the stock price went up 0.074%.
Which hedge fund is a major shareholder of Masimo Corp.?
Currently, no hedge funds are holding shares in MASI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Masimo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$180.00 (0.94% Upside)
$180.00 (0.94% Upside)
Blogger Sentiment
Bullish
MASI Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 616.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.8%
Last 30 Days ▲ 1.0%
Last 30 Days ▲ 1.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.71%
12-Months-Change
Fundamentals
Return on Equity
-17.21%
Trailing 12-Months
Asset Growth
-35.30%
Trailing 12-Months
Company Description
Masimo Corp.
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
MASI Stock 12 Month Forecast
Average Price Target
$180.00
▲(0.94% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---